Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy

Journal of Clinical Microbiology

Volumn 43, Issue 8, 2005, Pages 4175-4177

  Marzocchetti, Angela ^a   Di Giambenedetto, Simona ^a   Cingolani, Antonella ^a   Ammassari, Adriana ^a   Cauda, Roberto ^a   De Luca, Andrea ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; JC VIRUS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; VIRUS DETECTION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

HUMAN IMMUNODEFICIENCY VIRUS; JC VIRUS;

EID: 23744496308     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.8.4175-4177.2005     Document Type: Article

References (16)

1. Antinori, A., A. Ammassari, A. De Luca, A. Cingolani, R. Murri, G. Scoppettuolo, M. Fortini, T. Tartaglione, L. M. Larocca, G. Zannoni, P. Cattani, R. Grillo, R. Roselli, M. Iacoangeli, M. Scerrati, and L. Ortona. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 48:687-694.
2. Antinori, A., A. Ammassari, M. L. Giancola, A. Cingolani, S. Grisetti, R. Murri, L. Alba, B. Ciancio, F. Soldani, D. Larussa, G. Ippolito, and A. De Luca. 2001. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. J. Neurovirol. 7:323-328.
3. Antinori, A., A. Cingolani, P. Lorenzini, M. L. Giancola, I. Uccella, S. Bossolasco, S. Grisetti, F. Moretti, B. Vigo, M. Bongiovanni, B. Del Grosso, M. I. Arcidiacono, G. C. Fibbia, M. Mena, M. G. Finazzi, G. Guaraldi, A. Ammassari, A. d'Arminio Monforte, P. Cinque, A. De Luca, et al. 2003. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J. Neurovirol. 9(Suppl. 1):47-54.
4. Berger, J. R., A. Chauhan, D. Galey, and A. Nath. 2001. Epidemiological evidence and molecular basis of interactions between HIV and JC virus. J. Neurovirol. 7:329-338.
5. Berger, J. R., and M. Concha. 1995. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J. Neurovirol. 1:5-18.
6. Berger, J. R., and E. O. Major. 1999. Progressive multifocal leukoencephalopathy. Semin. Neurol. 19:193-200.
7. Cinque, P., I. J. Koralnik, and D. B. Clifford. 2003. The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology. J. Neurovirol. 9(Suppl. 1):88-92.
8. De Luca, A., M. L. Giancola, A. Ammassari, S. Grisetti, A. Cingolani, D. Larussa, L. Alba, R. Murri, G. Ippolito, R. Cauda, A. Monforte, and A. Antinori. 2001. Potent Antiretroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencepalophathy: extended follow-up and an observational study. J. Neurovirol. 7:364-368.
9. De Luca, A., M. L. Giancola, A. Ammassari, S. Grisetti, M. G. Paglia, M. Gentile, A. Cingolani, R. Murri, G. Liuzzi, A. D. Monforte, and A. Antinori. 2000. The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. J. Infect. Dis. 182:1077-1083.
10. De Luca, A., M. L. Giancola, A. Cingolani, A. Ammassari, L. Gillini, R. Murri, and A. Antinori. 1999. Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS associated progressive multifocal leukoencephalopathy. Clin. Infect. Dis. 28:624-628.
11. Gibson, P. E., S. D. Gardner, and A. M. Field. 1986. Use of a molecular probe for detecting JCV DNA directly in human brain material. J. Medical Virology 18:87-95.
12. Karahalios, D., R. Breit, M. Dal Canto, and M. Levy. 1992. Progressive multifocal leukoencephalopathy inpatients with HIV infection: lack of impact of early diagnosis by stereotactic brain biopsy. J. Acquired Immune Defic. Syndr. 5:1030-1038.
13. McGuire, D., H. Barhite, H. Hollander, and M. Miles. 1995. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann. Neurol. 37:395-399.
14. Sadfar, A., R. J. Rubocki, J. A. Horvath, K. K. Narayan, and L. Waldron. 2002. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin. Infect. Dis. 35:1250-1257.
15. Weber, T., R. W. Turner, S. Frye, W. Luke, H. A. Kretzschmar, W. Luer, and G. Hunsmann. 1994. Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluid. AIDS 8:49-57.
16. Weber, T., R. W. Turner, S. Frye, J. B. Ruf, Haas, E. Schielke, H. D. Pohle, W. Luke, W. Luer, K. Felgenhauer, et al. 1994. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J. Infect. Dis. 169:1138-1141.